Allakos Inc (ALLK)
1.10
-0.03
(-2.65%)
USD |
NASDAQ |
May 02, 16:00
1.27
+0.17
(+15.45%)
After-Hours: 05:19
Allakos Enterprise Value: -73.40M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | -73.40M |
| May 01, 2024 | -70.74M |
| April 30, 2024 | -77.82M |
| April 29, 2024 | -73.40M |
| April 26, 2024 | -80.48M |
| April 25, 2024 | -81.36M |
| April 24, 2024 | -80.48M |
| April 23, 2024 | -77.82M |
| April 22, 2024 | -76.94M |
| April 19, 2024 | -76.05M |
| April 18, 2024 | -76.94M |
| April 17, 2024 | -76.94M |
| April 16, 2024 | -77.82M |
| April 15, 2024 | -75.17M |
| April 12, 2024 | -72.51M |
| April 11, 2024 | -63.66M |
| April 10, 2024 | -68.08M |
| April 09, 2024 | -64.54M |
| April 08, 2024 | -70.74M |
| April 05, 2024 | -65.43M |
| April 04, 2024 | -61.88M |
| April 03, 2024 | -57.46M |
| April 02, 2024 | -61.00M |
| April 01, 2024 | -62.77M |
| March 28, 2024 | -59.23M |
| Date | Value |
|---|---|
| March 27, 2024 | -58.32M |
| March 26, 2024 | -57.44M |
| March 25, 2024 | -54.80M |
| March 22, 2024 | -52.16M |
| March 21, 2024 | -57.44M |
| March 20, 2024 | -55.68M |
| March 19, 2024 | -60.95M |
| March 18, 2024 | -62.71M |
| March 15, 2024 | -55.68M |
| March 14, 2024 | -56.12M |
| March 13, 2024 | -48.21M |
| March 12, 2024 | -53.92M |
| March 11, 2024 | -44.26M |
| March 08, 2024 | -45.13M |
| March 07, 2024 | -54.80M |
| March 06, 2024 | -57.44M |
| March 05, 2024 | -47.77M |
| March 04, 2024 | -43.82M |
| March 01, 2024 | -26.68M |
| February 29, 2024 | -40.74M |
| February 28, 2024 | -34.78M |
| February 27, 2024 | -30.39M |
| February 26, 2024 | -42.68M |
| February 23, 2024 | -51.45M |
| February 22, 2024 | -53.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-146.41M
Minimum
Mar 15 2022
7.584B
Maximum
Dec 28 2020
2.081B
Average
1.607B
Median
Jun 10 2019
Enterprise Value Benchmarks
| Tonix Pharmaceuticals Holding Corp | 1.18M |
| RAPT Therapeutics Inc | 124.04M |
| NovaBay Pharmaceuticals Inc | 2.666M |
| Palatin Technologies Inc | 23.59M |
| iBio Inc | 16.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -62.55M |
| Total Expenses (Quarterly) | 64.98M |
| EPS Diluted (Quarterly) | -0.72 |
| Earnings Yield | -194.5% |